Many proteins are being found to bind inositol phosphates with varying degrees of specificity; the variety of domains that can bind inositol phosphates suggests convergent evolution, but the functions of most of the binding sites are not yet clear. Perhaps we should not be surprised if, as more and more intracellular inositol phosphates and lipids are discovered, the number of proteins found to bind them also grows. But as the number of inositol phosphate-binding proteins increases, one might hope that some pattern would emerge in the form of some similarity in sequence or function of the inositol phosphate-binding proteins. So far, however, the contrary seems to be the case. Convergent evolution appears to have operated in such a way that almost any protein domain can bind an inositol phosphate if required.
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PH domains
The best example of the specialized use of a general domain to bind inositol phosphates may be the pleckstrin homology (PH) domain of phospholipase C ␦1 (PLC␦1). PH domains vary considerably in sequence, and presumably therefore in function [1] . Like many other PH domains [2] , that of PLC␦1 can bind the enzyme's substrate, phosphatidylinositol 4,5-bisphosphate (PIP 2 ), but it is unlikely to be part of the active site of PLC␦1, as the enzyme functions as a PLC, albeit with different kinetics, without its PH domain (see [2] for references). Although all PLCs have such PH domains, that of PLC␦1 is unusual in that it binds the enzyme's product, inositol 1,4,5-triphosphate (IP 3 ), with a high affinity. IP 3 binding inhibits the enzyme's activity, providing regulation by product inhibition and so preventing uncontrolled activation -likely to be particularly useful given that, as far as we know, PLC␦s are regulated only by Ca 2+ , and not directly by receptors.
This probable biological significance of IP 3 binding is supported by its remarkable isomeric specificity (see [2] ), and we now have a beautiful three-dimensional structure of the PLC␦1 PH domain to explain how this specific binding is mediated [2] . It appears that several discrete residuesmostly positively charged, as one might expect -in the first three ␤ sheets of the PH domain contribute to the formation of a highly specific IP 3 -binding site (Fig. 1 ). As these residues are different from their equivalents in other PH domains, we can understand why most PH domains do not bind IP 3 . We use the word 'most' instead of 'all' in the preceding sentence because the PH domains of several other proteins -dynamin, spectrin and pleckstrin, for example -do bind IP 3 , but the binding is very much weaker. Ferguson et al. [2] discuss this, and show how the unique structure of the PLC␦1 PH domain accounts for the much higher affinity by having more residues that can interact directly with IP 3 .
So IP 3 binding is probably a specific function for this particular PH domain. It will be interesting to see threedimensional structures showing how this and other PH domains bind PIP 2 , as this may help us to evaluate how many such PIP 2 -binding sites are physiologically relevant. The problem with investigating the binding of a lipid suspension (with or without detergent) to a protein in aqueous solution is that an otherwise very weak interaction of the lipid headgroup with any domain (such as a PH A ribbon diagram of PH domain of PLC␦ with bound IP 3 [2] . (Graphic courtesy of Mark Lemmon.) domain) can be distorted in the binding assay to an apparently strong binding, simply because the presence of hydrophobic regions in the protein makes the bound lipid feel happier staying where it is rather than dissociating back into the very polar environment of the solution. It is possible that many apparent high-affinity binding sites for PIP 2 in proteins never get to see PIP 2 in vivo.
C2 domains
The other clear example of a phospholipid-binding domain that is 'adapted' for inositol phosphate binding is the 'C2B domain', which is found in several proteins. C2 domains were first described as Ca 2+ -dependent phospholipid-binding domains in protein kinase C, and have been extensively examined with respect to their properties and functions in proteins of the synaptotagmin family. The synaptotagmins have two adjacent C2 domains, C2A and C2B, and the C2A domain binds phospholipids by a Ca 2+ -dependent mechanism, whereas the C2B domain binds them independently of Ca 2+ .
The ability of C2 domains to bind inositol phosphates was discovered by chance by Fukuda et al. [3] , who purified synaptotagmin II as an IP 4 -binding protein. They showed that the IP 4 was binding to the protein's C2B domain (IP 6 binds with a higher affinity than IP 4 , so from now on we shall call this an IP 6 -binding domain). Moreover, by comparing the sequence of the synaptotagmin II C2B domain with C2B domains of some other proteins that they found do not bind IP 6 , Fukuda et al. [3] were able to identify some lysine residues that are critical for IP 6 binding. All synaptotagmin C2 domains have a lysine/arginine-rich stretch, and in the C2B domain of synaptotagmin II there is a remarkable cluster of consecutive lysines that are clearly responsible for the the IP 6 binding. However, further studies from the same laboratory have shown that things are not quite that simple.
In their second paper on this topic, Fukuda et al. [4] investigated IP 6 binding (again using [ 3 H]-IP 4 as the ligand) by the C2B domains of synaptotagmins III and IV, and they found that, despite having an identical pattern of lysines and arginines in the crucial region to synaptotagmin II, the C2B domain of synaptotagmin III does not bind IP 6 at all. It appears from experiments with hybrid domains that, in the synaptotagmin III C2B domain, residues on the carboxyterminal side of the lysine/arginine-rich region have an inhibitory influence of some kind on IP 6 binding, perhaps by their effect on the way the C2B domain folds. There is, however, no immediately obvious (at least to us) difference in the C2B domain sequences that would explain such an inhibitory influence. Solving this puzzle may need the determination of further three-dimensional structures.
Having said that, we believe that we may nevertheless have gained some possible insight into the nature of this phenomenon recently. We purified (from platelets) and cloned the gene for a putative IP 4 receptor, a highly-specific (1,3,4,5)IP 4 -binding protein which also has two C2 domains similar to those in the synaptotagmins [5] ; the protein is a member of the GAP1 family so we call it GAP1 IP4BP . This protein's affinity for inositol phosphates is very different from that of synaptotagmin II, in that it is extraordinarily specific for (1,3,4,5)IP 4 (IP 6 , for example, binds more than two orders of magnitude more weakly than does IP 4 ). The work of Fukuda et al. [3] , however, suggested to us that the lysine/arginine-rich stretch of the C2B domain of GAP1 IP4BP is again the likely IP 4 -binding site.
We have confirmed the likelihood of this suggestion recently, by finding that a 25-residue peptide from the C2B domain of GAP1 IP4BP , containing the highly basic sequence KKTKVKKK, binds IP 4 with an affinity and specificity not far removed from that of the native protein (unpublished data). Why we bring this up as relevant here is that such a peptide is unlikely to have extensive tertiary structure, and indeed, in the only C2 domain of known three-dimensional structure -the C2A domain of synaptotagmin I -the lysine-rich stretch is unstructured [6] . We believe, therefore, that binding of IP 4 to a C2 domain may involve an 'induced fit' -that is, the unstructured polypeptide chain may coil around to form a basket-like structure, allowing the lysines or arginines to interact with the phosphates of the IP 4 . We have made a space-filling model of the KKTKVKKK peptide, and find that it can indeed coil to form a remarkably specific IP 4 -binding structure.
If the C2B domains of synaptotagmins II and IV bind IP 6 in a similar way, this could explain the observation that proteins with very similar sequences -such as synaptotagmin III and synaptotagmin II -have very different IP 6 -binding properties. Thus, a small difference in sequence might affect the domain structure in such a way as to prevent, by steric hindrance, the polypeptide chain from coiling around the inositol phosphate ligand, and this would very greatly reduce the protein's binding affinity. If true, then this would be very different from the way in which the PH domain of PLC␦1 binds IP 3 , and it will be fascinating to find out whether other proteins that bind IP 6 use a similar mechanism.
Other IP 6 -binding proteins
We now know quite a large handful of other IP 6 -binding proteins (for references, see [7] ). The first clear identification of such a protein was by Ann Theibert and colleagues, who showed that an IP 4 /IP 6 -binding protein -again favouring IP 6 -purified from brain is AP-2, one of the clathrin assembly proteins. Another protein involved in clathrin assembly, AP-3, was recently shown to bind IP 6 . Moreover, coatomer, another protein complex involved in vesicle assembly and movement, but in this instance in the Golgi apparatus and endoplasmic reticulum, also binds IP 6 .
Here, at least, some functional pattern is suggested. In each of these examples, IP 6 has been shown to inhibit the relevant protein function in vitro; it has also been shown to inhibit exocytosis of synaptic vesicles [8] , in which synaptotagmin II is involved, but whether this pharmacological phenomenon reflects a physiological control mechanism remains unproven.
We also don't know whether IP 6 actually modulates the structures of the proteins to which it binds allostericallyperhaps by an induced-fit, as discussed -or whether it merely changes the charge distribution on interacting domains. In these other IP 6 -binding proteins, the IP 6 binding sites have not yet been identified, though they all contain lysine/arginine-rich regions. Most of the groups studying these interactions have noted a couple of problems for possible physiological functions of IP 6 binding: first, the affinities observed suggest that, unless there is marked compartmentalization of IP 6 in the cell or some other factor modulates the binding, all these binding sites will be permanently saturated with IP 6 ; and second, IP 6 levels do not change very much or at all rapidly in intact cells, as far as we know.
The three most obvious possible resolutions to this conundrum are as follows. First, that these binding sites actually recognize something else in vivo, phospholipids such as PIP 2 or PIP 3 , for example (of course, this is not to say that IP 6 could not compete for, and therefore modulate, the lipid binding). Second, bound IP 6 may act as some kind of 'bridge' between proteins: this may be true, for example, in the case of clathrin AP-2 and the C2B domain of synaptotagmin I [9] , which interact tightly and both of which bind IP 6 [3] -the analogy of oil between the cogs of a gear system is not entirely inappropriate. Third, as suggested recently by Vogelmeier et al. [10] , phosphorylation of IP 6 may act as an energy source for vesicle fusion/secretion.
The presence in cells of pyrophosphate (PP)-containing inositol phosphates -IP 5 -(PP) and IP 4 -(PP) 2 , more loosely termed IP 7 and IP 8 , respectively -has puzzled all those working in the inositol phosphate field ever since they were discovered. Their interaction with IP 6 -binding sites has, where studied, been found to be as tight or tighter than IP 6 (see [7] for references), and metabolic studies reveal that they are turning over much more quickly than IP 6 (see [7] ). Vogelmeier et al. [10] recently purified an IP 6 kinase and found that it would effectively transfer phosphate from IP 7 back to ADP to make ATP, so they suggested that the pyrophosphate-containing inositol phosphates may be acting as a localized energy source -a role akin to that of creatine phosphate in muscle, though creatine phosphate is not tightly localized within the cell. We wonder if the involvement is even more direct: if the pyrophosphate-containing inositol phosphates were actually bound to one or more proteins involved in the membrane fusion events, then hydrolysis of the high energy pyrophosphate bond may provide the driving force for the fusion.
Other inositol phosphate-binding proteins
Other inositol phosphate-binding proteins form another large group. Kanematsu et al. [11] , for example, have described what appears to be an (1,4,5,6 )IP 4 -binding protein in brain, and there must be an (3,4,5,6)IP 4 -binding protein in some cells to explain the specific physiological effects of this compound [12] . Theibert et al. [13] have found at least two unidentified proteins in brain that bind IP 4 with an impressive specificity, and Reiser et al. [14] have found another. Aldolase is yet another protein whose inositol phosphate-binding properties are known but still of unproven significance [15] . Very recently, vinculin has also been identified as an IP 6 -binding protein by O'Rourke et al. [16] . Moreover, there are at least two highly specific IP 3 -binding proteins to be included -the receptor and 3-kinase for this molecule -which bear no sequence homology either to each other, or to the PH domain of PLC␦1. We start to get the impression of convergent evolution run amok! Finally let us not forget the grand-daddy of them all, haemoglobin. In erythrocytes from some species -such as birds and turtles -this protein is allosterically modulated by IP 4 and IP 5 (for references see [17] ). This is not so in the embryos of these species, in which 2,3-bisphosphoglycerate fulfills this function (as it does in our red cells), but just before hatching a switch occurs to give a major physiological function to these inositol polyphosphates. Perhaps this is the system we should study to help us understand why evolution has done this kind of thing so often.
